S&P 500   3,246.96 (-1.91%)
DOW   26,264.95 (-1.48%)
QQQ   269.00 (-2.67%)
AAPL   108.72 (-5.72%)
MSFT   201.15 (-1.74%)
FB   263.46 (-6.19%)
GOOGL   1,626.98 (+4.50%)
AMZN   3,037.84 (-5.39%)
TSLA   387.24 (-5.74%)
NVDA   494.50 (-5.08%)
BABA   304.86 (-2.46%)
CGC   18.68 (-0.53%)
GE   7.41 (+0.54%)
MU   49.83 (-1.29%)
AMD   74.79 (-4.14%)
T   26.99 (+0.86%)
F   7.73 (-2.15%)
ACB   4.02 (-1.71%)
GILD   57.98 (-0.94%)
NIO   30.61 (-4.31%)
NFLX   476.00 (-5.59%)
BA   143.92 (-2.95%)
DIS   120.83 (-0.58%)
S&P 500   3,246.96 (-1.91%)
DOW   26,264.95 (-1.48%)
QQQ   269.00 (-2.67%)
AAPL   108.72 (-5.72%)
MSFT   201.15 (-1.74%)
FB   263.46 (-6.19%)
GOOGL   1,626.98 (+4.50%)
AMZN   3,037.84 (-5.39%)
TSLA   387.24 (-5.74%)
NVDA   494.50 (-5.08%)
BABA   304.86 (-2.46%)
CGC   18.68 (-0.53%)
GE   7.41 (+0.54%)
MU   49.83 (-1.29%)
AMD   74.79 (-4.14%)
T   26.99 (+0.86%)
F   7.73 (-2.15%)
ACB   4.02 (-1.71%)
GILD   57.98 (-0.94%)
NIO   30.61 (-4.31%)
NFLX   476.00 (-5.59%)
BA   143.92 (-2.95%)
DIS   120.83 (-0.58%)
S&P 500   3,246.96 (-1.91%)
DOW   26,264.95 (-1.48%)
QQQ   269.00 (-2.67%)
AAPL   108.72 (-5.72%)
MSFT   201.15 (-1.74%)
FB   263.46 (-6.19%)
GOOGL   1,626.98 (+4.50%)
AMZN   3,037.84 (-5.39%)
TSLA   387.24 (-5.74%)
NVDA   494.50 (-5.08%)
BABA   304.86 (-2.46%)
CGC   18.68 (-0.53%)
GE   7.41 (+0.54%)
MU   49.83 (-1.29%)
AMD   74.79 (-4.14%)
T   26.99 (+0.86%)
F   7.73 (-2.15%)
ACB   4.02 (-1.71%)
GILD   57.98 (-0.94%)
NIO   30.61 (-4.31%)
NFLX   476.00 (-5.59%)
BA   143.92 (-2.95%)
DIS   120.83 (-0.58%)
S&P 500   3,246.96 (-1.91%)
DOW   26,264.95 (-1.48%)
QQQ   269.00 (-2.67%)
AAPL   108.72 (-5.72%)
MSFT   201.15 (-1.74%)
FB   263.46 (-6.19%)
GOOGL   1,626.98 (+4.50%)
AMZN   3,037.84 (-5.39%)
TSLA   387.24 (-5.74%)
NVDA   494.50 (-5.08%)
BABA   304.86 (-2.46%)
CGC   18.68 (-0.53%)
GE   7.41 (+0.54%)
MU   49.83 (-1.29%)
AMD   74.79 (-4.14%)
T   26.99 (+0.86%)
F   7.73 (-2.15%)
ACB   4.02 (-1.71%)
GILD   57.98 (-0.94%)
NIO   30.61 (-4.31%)
NFLX   476.00 (-5.59%)
BA   143.92 (-2.95%)
DIS   120.83 (-0.58%)
Log in
OTCMKTS:SKBI

Skystar Bio-Pharmaceutical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume25 shs
Average Volume1,983 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-175.12
Skystar Bio-Pharmaceutical Company researches, develops, produces, markets, and sells veterinary healthcare and medical care products in the People's Republic of China. The company offers micro-organism products, veterinary medicines for poultry and livestock, feed additives, and bio-pharmaceutical veterinary vaccines. It markets its products through distributers and franchise distributors, as well as directly to customers. The company is headquartered in Xi'an, the People's Republic of China.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.46 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SKBI
Previous SymbolNASDAQ:SKBI
CUSIPN/A
CIK1076939
Webwww.skystarbio-pharmaceutical.com
Phone86-29-8819-3188
Employees318

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares8,700,000
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive SKBI News and Ratings via Email

Sign-up to receive the latest news and ratings for SKBI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Skystar Bio-Pharmaceutical (OTCMKTS:SKBI) Frequently Asked Questions

Who are some of Skystar Bio-Pharmaceutical's key competitors?

Some companies that are related to Skystar Bio-Pharmaceutical include Acusphere (ACUS), Aeolus Pharmaceuticals (AOLS), Affymax (AFFY), American Oriental Bioengineering (AOBI), Anthera Pharmaceuticals (ANTH), Aoxing Pharmaceutical (AOXG), ARYx Therapeutics (ARYX), AtheroNova (AHROQ), Biostar Pharmaceuticals (BSPM), Bohai Pharmaceuticals Group (BOPH), China Botanic Pharmaceutical (CBPI), China Dongsheng International (CDSG), China Health Industries (CHHE), Diadexus (DDXSQ) and EPIRUS Biopharmaceuticals (EPRSQ).
View all competitors.

What other stocks do shareholders of Skystar Bio-Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Skystar Bio-Pharmaceutical investors own include Uranium Energy (UEC), XOMA (XOMA), Abraxas Petroleum (AXAS), China Green Agriculture (CGA), CTI BioPharma (CTIC), Gulf Resources (GURE), Inovio Pharmaceuticals (INO), Spark Networks (LOV), MGT Capital Investments (MGTI) and (ONCYF) (ONCYF).

Who are Skystar Bio-Pharmaceutical's key executives?

Skystar Bio-Pharmaceutical's management team includes the following people:
  • Mr. Weibing Lu, Chairman and Chief Exec. Officer (Age 56)

What is Skystar Bio-Pharmaceutical's stock symbol?

Skystar Bio-Pharmaceutical trades on the OTCMKTS under the ticker symbol "SKBI."

How do I buy shares of Skystar Bio-Pharmaceutical?

Shares of SKBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is Skystar Bio-Pharmaceutical?

Skystar Bio-Pharmaceutical has a market capitalization of $0.00. Skystar Bio-Pharmaceutical employs 318 workers across the globe.

What is Skystar Bio-Pharmaceutical's official website?

The official website for Skystar Bio-Pharmaceutical is www.skystarbio-pharmaceutical.com.

How can I contact Skystar Bio-Pharmaceutical?

Skystar Bio-Pharmaceutical's mailing address is RM 10601 JIEZUO PLAZA NO. 4 FENGHUI ROAD SOUTH, XIAN F4, . The healthcare company can be reached via phone at 86-29-8819-3188 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.